drugset / Trial / NCT01127282
The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A
RandomizedParallel-groupSingle-blindTreatment
Summary
Influenza continues to inflict an important burden on health-care systems. The 2009 H1N1 influenza virus first appeared in Mexico and the United States in March and April 2009 and has swept the globe with unprecedented speed. The aim of this study is to evaluate effect of supplement vitamin on the clinical course of patients with acute respiratory illness suspected novel H1N1 infection.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-06
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin A | Unknown | 15 mg | Oral |
| Subject | Vitamin C | Other / unclassified | 500 mg | Oral |
| Subject | Vitamin E | Other / unclassified | 400 iu | Oral |